BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11782091)

  • 1. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry.
    Fetsch PA; Simsir A; Brosky K; Abati A
    Diagn Cytopathol; 2002 Jan; 26(1):61-6. PubMed ID: 11782091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block.
    Gong Y; Sun X; Michael CW; Attal S; Williamson BA; Bedrossian CW
    Diagn Cytopathol; 2003 Jan; 28(1):1-5. PubMed ID: 12508174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion.
    Ueda J; Iwata T; Ono M; Takahashi M
    Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and immunocytochemical performances of effusion cell blocks prepared using 3 different methods.
    Jing X; Li QK; Bedrossian U; Michael CW
    Am J Clin Pathol; 2013 Feb; 139(2):177-82. PubMed ID: 23355202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultured anaplastic cell lines as immunocytochemistry controls: a comparison of ThinPrep-processed smears and conventional air-dried cytospins.
    Wiatrowska BA; Berner A; Torlakovic G; Emilsen E; Mykelbost GL; Torlakovic E
    Diagn Cytopathol; 2001 Nov; 25(5):303-8. PubMed ID: 11747220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
    Ko EC; Jhala NC; Shultz JJ; Chhieng DC
    Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers for metastatic adenocarcinoma in serous effusion specimens.
    Shield PW; Callan JJ; Devine PL
    Diagn Cytopathol; 1994; 11(3):237-45. PubMed ID: 7532566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunocytochemical sensitivity between formalin-fixed and alcohol-fixed specimens reveals the diagnostic value of alcohol-fixed cytocentrifuged preparations in malignant effusion cytology.
    Ikeda K; Tate G; Suzuki T; Mitsuya T
    Am J Clin Pathol; 2011 Dec; 136(6):934-42. PubMed ID: 22095380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
    Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology.
    Fetsch PA; Simsir A; Abati A
    Diagn Cytopathol; 2001 Sep; 25(3):158-61. PubMed ID: 11536437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytodiagnosis and cytomorphologic analysis of hematolymphoid malignancy in serous effusion: a study of 23 cases].
    He SR; Peng WX; Sun MJ; Yang L; He L; Su XL; He Q; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):691-5. PubMed ID: 23302312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology.
    Bedrossian CW
    Diagn Cytopathol; 1998 Feb; 18(2):141-9. PubMed ID: 9484644
    [No Abstract]   [Full Text] [Related]  

  • 18. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
    Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
    Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.